319 related articles for article (PubMed ID: 25843224)
1. Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment.
Tomita H; Hagii J; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Sasaki S; Yasujima M; Okumura K
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1430-7. PubMed ID: 25843224
[TBL] [Abstract][Full Text] [Related]
2. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
Yamamoto R; Nakae Y; Tanaka F; Johkura K
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
[TBL] [Abstract][Full Text] [Related]
3. Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.
Nakamura A; Ago T; Kamouchi M; Hata J; Matsuo R; Kuroda J; Kuwashiro T; Sugimori H; Kitazono T;
Stroke; 2013 Nov; 44(11):3239-42. PubMed ID: 23963334
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].
Tomoda M; Yasaka M; Nakanishi Y; Takaguchi G; Nakamura A; Gotoh S; Kuwashiro T; Okada Y
Brain Nerve; 2017 May; 69(5):571-576. PubMed ID: 28479535
[TBL] [Abstract][Full Text] [Related]
5. Stroke Severity in Patients on Non-Vitamin K Antagonist Oral Anticoagulants with a Standard or Insufficient Dose.
Jung YH; Choi HY; Lee KY; Cheon K; Han SW; Park JH; Cho HJ; Park HJ; Nam HS; Heo JH; Lee HS; Kim YD
Thromb Haemost; 2018 Dec; 118(12):2145-2151. PubMed ID: 30453351
[TBL] [Abstract][Full Text] [Related]
6. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
7. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
8. Impact of Sex Difference on Severity and Functional Outcome in Patients with Cardioembolic Stroke.
Tomita H; Hagii J; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Baba Y; Sasaki S; Uchizawa T; Iwata M; Matsumoto S; Shoji Y; Tanno T; Osanai T; Yasujima M; Okumura K
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2613-8. PubMed ID: 26341732
[TBL] [Abstract][Full Text] [Related]
9. Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.
Hellwig S; Grittner U; Audebert H; Endres M; Haeusler KG
Europace; 2018 Apr; 20(4):569-574. PubMed ID: 28460024
[TBL] [Abstract][Full Text] [Related]
10. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
Renda G; di Nicola M; De Caterina R
Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
[TBL] [Abstract][Full Text] [Related]
11. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.
Indredavik B; Rohweder G; Lydersen S
J Intern Med; 2005 Aug; 258(2):133-44. PubMed ID: 16018790
[TBL] [Abstract][Full Text] [Related]
12. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A
J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304
[TBL] [Abstract][Full Text] [Related]
13. A Therapeutic International Normalized Ratio Results in Smaller Infarcts and Better Outcomes for Patients with Ischemic Stroke.
Merbach D; Lawrence E; Mallick D; Marsh EB
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104278. PubMed ID: 31326271
[TBL] [Abstract][Full Text] [Related]
14. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
15. Can early effective anticoagulation prevent new lesions on magnetic resonance imaging in acute cardioembolic stroke?
Nomura E; Ohshita T; Imamura E; Wakabayashi S; Kajikawa H; Matsumoto M
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2099-2104. PubMed ID: 25106835
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin.
Melmed KR; Lyden P; Gellada N; Moheet A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
[TBL] [Abstract][Full Text] [Related]
18. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
19. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
